Contra Zynerba Pharmac
13F holders, Q1 2025 (March 31)1holders −1
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Contra Zynerba Pharmac in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Financial Gravity Asset Management, Inc. ($0).
- Company
- Contra Zynerba Pharmac
- CUSIP
- 989CVR022
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 100 shares sold, net −100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Financial Gravity Asset Management, Inc. | 0.00% | — | 3,600 | $0 |
"% of holder's portfolio" is CONTRA ZYNERBA PHARMAC's weight in each manager's 13F, not the share of Contra Zynerba Pharmac the manager owns.